Annual EBITDA
-$10.90 M
-$17.50 K-0.16%
01 December 2022
Summary:
CERo Therapeutics Holdings annual earnings before interest, taxes, depreciation & amortization is currently -$10.90 million, with the most recent change of -$17.50 thousand (-0.16%) on 01 December 2022. CERO annual EBITDA is now -0.16% below its all-time high of -$10.88 million, reached on 01 December 2021.CERO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.40 M
-$1.97 M-81.03%
01 September 2024
Summary:
CERo Therapeutics Holdings quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.40 million, with the most recent change of -$1.97 million (-81.03%) on 01 September 2024. Over the past year, it has dropped by -$3.15 million (-251.00%). CERO quarterly EBITDA is now -251.00% below its all-time high of -$1.25 million, reached on 01 September 2023.CERO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$6.83 M
-$3.15 M-85.41%
01 September 2024
Summary:
CERo Therapeutics Holdings TTM earnings before interest, taxes, depreciation & amortization is currently -$6.83 million, with the most recent change of -$3.15 million (-85.41%) on 01 September 2024. Over the past year, it has dropped by -$1.28 million (-23.02%). CERO TTM EBITDA is now -215.68% below its all-time high of -$2.16 million, reached on 01 March 2023.CERO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -251.0% | -23.0% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CERO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -0.2% | at low | -251.0% | at low | -215.7% | at low |
| 5 y | 5 years | -0.2% | at low | -251.0% | at low | -215.7% | at low |
| alltime | all time | -0.2% | at low | -251.0% | at low | -215.7% | at low |
CERo Therapeutics Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.40 M(+81.0%) | -$6.83 M(+85.4%) |
| June 2024 | - | -$2.43 M(+93.9%) | -$3.69 M(-33.7%) |
| Sept 2023 | - | -$1.25 M(-41.3%) | -$5.56 M(+29.2%) |
| June 2023 | - | -$2.14 M(-1.3%) | -$4.30 M(+98.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$2.16 M(-34.0%) | -$2.16 M(-34.0%) |
| Dec 2022 | -$10.90 M(+0.2%) | - | - |
| Mar 2022 | - | -$3.28 M | -$3.28 M |
| Dec 2021 | -$10.88 M | - | - |
FAQ
- What is CERo Therapeutics Holdings annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings quarterly EBITDA year-on-year change?
- What is CERo Therapeutics Holdings TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for CERo Therapeutics Holdings?
- What is CERo Therapeutics Holdings TTM EBITDA year-on-year change?
What is CERo Therapeutics Holdings annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CERO is -$10.90 M
What is the all time high annual EBITDA for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.88 M
What is CERo Therapeutics Holdings quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CERO is -$4.40 M
What is the all time high quarterly EBITDA for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.25 M
What is CERo Therapeutics Holdings quarterly EBITDA year-on-year change?
Over the past year, CERO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$3.15 M (-251.00%)
What is CERo Therapeutics Holdings TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CERO is -$6.83 M
What is the all time high TTM EBITDA for CERo Therapeutics Holdings?
CERo Therapeutics Holdings all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.16 M
What is CERo Therapeutics Holdings TTM EBITDA year-on-year change?
Over the past year, CERO TTM earnings before interest, taxes, depreciation & amortization has changed by -$1.28 M (-23.02%)